Alnylam Pharmaceuticals (ALNY) Raw Materials (2018 - 2026)
Alnylam Pharmaceuticals (ALNY) reported Raw Materials of $13.91 million for Q2 2026, down 39.2% from $22.87 million a year earlier but up 19.0% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Raw Materials (2018 - 2026) Analysis & Trends
At the end of FY2025, Alnylam Pharmaceuticals posted Raw Materials of $14.18 million, down 40.8% from FY2024.
- Raw Materials has a five-year compound annual growth rate of -25.9% (FY2020 to FY2025).
- By year, Raw Materials came in at $23.97 million in FY2024 (+2.7%), $23.35 million in FY2023 (+4.6%), $22.32 million in FY2022 (+51.2%) and $14.75 million in FY2021 (-76.8%).
- Five-year quarterly Raw Materials spans a low of $11.69 million in Q1 2026 and a high of $65.16 million in Q3 2021.
- Year over year, Raw Materials has now declined in each of the last six quarters, with an average decline of 17.1% over the last eight quarters.
- The high point for year-over-year Raw Materials in five years was Q4 2022 (growth of 51.2%); the low point was Q4 2021 (a decline of 76.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $11.69 million (Q1 2026), $14.18 million (Q4 2025) and $22.25 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Alnylam Pharmaceuticals | 30.06 Bn | 18.11 Bn | 992.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.91 Mn |
| Mar 31, 2026 | 11.69 Mn |
| Dec 31, 2025 | 14.18 Mn |
| Sep 30, 2025 | 22.25 Mn |
| Jun 30, 2025 | 22.87 Mn |
| Mar 31, 2025 | 23.40 Mn |
| Dec 31, 2024 | 23.97 Mn |
| Sep 30, 2024 | 22.37 Mn |
| Jun 30, 2024 | 26.02 Mn |
| Mar 31, 2024 | 25.40 Mn |
| Dec 31, 2023 | 23.35 Mn |
| Sep 30, 2023 | 20.12 Mn |
| Jun 30, 2023 | 17.45 Mn |
| Mar 31, 2023 | 22.88 Mn |
| Dec 31, 2022 | 22.32 Mn |
| Sep 30, 2022 | 17.72 Mn |
| Jun 30, 2022 | 19.14 Mn |
| Mar 31, 2022 | 20.37 Mn |
| Dec 31, 2021 | 14.75 Mn |
| Sep 30, 2021 | 65.16 Mn |
API Access
Alnylam Pharmaceuticals Raw Materials API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=raw-materials&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "raw-materials", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=raw-materials&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();